“Each month ended the same way, despite careful tracking and effort,” said a San Francisco-based patient in her early 30s, when discussing her struggle to conceive her first child. After nearly a year of trying and mounting disappointments, she realized something wasn’t right. “Ultimately, it was pregnancy test fail after fail after fail,” she said. … [Read more…]
Blog At RMA, we believe every patient deserves to feel heard, understood, and supported throughout their fertility journey. That’s why we’re launching our first Patient Advisory Councils (PACs) in the U.S., collaborative spaces where patients can share their experiences and help shape the future of care. The U.S. PAC began December 16, 2025, with monthly … [Read more…]
Blog Newly established Institute for Safety in Reproduction will lead the work of RMA’s PSO and drive system-wide advances in safety, science, and quality outcomes BASKING RIDGE, N.J.— July 25, 2025 – IVI RMA North America (IVI), a leader in fertility care and assisted reproduction, today announced the Institute for Safety in Reproductive Medicine (ISRM), … [Read more…]
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. Sarepta Therapeutics said Sunday that it was halting shipments of its Duchenne muscular dystrophy gene therapy for patients who can no longer walk, following the death of a second person who received the treatment. Sarepta disclosed … [Read more…]